The International Prognostic Index Correlates to Survival in Patients With Aggressive Lymphoma in Relapse: Analysis of the PARMA Trial

作者: Thomas Bachelot , Pierre Biron , C. Sebban , C. Guglielmi , Jean Yves Blay

DOI: 10.1182/BLOOD.V92.10.3562

关键词:

摘要: The objectives of the present study were to investigate prognostic value International Prognostic Index (IPI) at relapse in 215 patients with intermediate- or high-grade non-Hodgkin's lymphoma (NHL) included PARMA trial. IPI was available 204 (95%) these patients. Response rates 2 courses DHAP 77%, 54%, 55%, and 42% an 0, 1, 3, respectively (P 0 <.05), but not 0. In conclusion, results show that correlates response overall survival aggressive NHL enables us identify a significantly different outcome among those treated conventional chemotherapy alone.

参考文章(24)
F Cabanillas, FB Hagemeister, GP Bodey, EJ Freireich, IMVP-16: An Effective Regimen for Patients With Lymphoma Who Have Relapsed After Initial Combination Chemotherapy Blood. ,vol. 60, pp. 693- 697 ,(1982) , 10.1182/BLOOD.V60.3.693.693
C Haioun, E Lepage, C Gisselbrecht, Y Bastion, B Coiffier, P Brice, A Bosly, B Dupriez, C Nouvel, H Tilly, P Lederlin, P Biron, J Brière, P Gaulard, F Reyes, Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. Journal of Clinical Oncology. ,vol. 15, pp. 1131- 1137 ,(1997) , 10.1200/JCO.1997.15.3.1131
P McLaughlin, M Fridrik, S Tucker, S Jagannath, FB Hagemeister, JR Redman, F Swan, WS Velasquez, F Cabanillas, P Salvador, Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood. ,vol. 71, pp. 117- 122 ,(1988) , 10.1182/BLOOD.V71.1.117.117
A P Rapoport, J M Rowe, P A Kouides, R A Duerst, C N Abboud, J L Liesveld, C H Packman, S Eberly, M Sherman, M A Tanner, One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome. Journal of Clinical Oncology. ,vol. 11, pp. 2351- 2361 ,(1993) , 10.1200/JCO.1993.11.12.2351
A Bosly, B Coiffier, C Gisselbrecht, H Tilly, G Auzanneau, F Andrien, R Herbrecht, M Legros, Y Devaux, J Jaubert, Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen. Journal of Clinical Oncology. ,vol. 10, pp. 1615- 1623 ,(1992) , 10.1200/JCO.1992.10.10.1615
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
Thierry Philip, Cesare Guglielmi, Anton Hagenbeek, Renier Somers, Hans Van Der Lelie, Dominique Bron, Pieter Sonneveld, Christian Gisselbrecht, Jean-Yves Cahn, Jean-Luc Harousseau, Bertrand Coiffier, Pierre Biron, Franco Mandelli, Franck Chauvin, Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma The New England Journal of Medicine. ,vol. 333, pp. 1540- 1545 ,(1995) , 10.1056/NEJM199512073332305
David U Himmelstein, Steffie Woolhandler, Pitfalls of private medicine: health care in the USA. The Lancet. ,vol. 324, pp. 391- 394 ,(1984) , 10.1016/S0140-6736(84)90555-5
Ruben Saez, Steve Dahlberg, Frederick R. Appelbaum, Robert J. Hartsock, Frederick Lemaistre, Charles A. Coltman, Richard I. Fisher, Autologous bone marrow transplantation in adults with non-Hodgkin's lymphoma: a Southwest Oncology Group study. Hematological Oncology. ,vol. 12, pp. 75- 85 ,(1994) , 10.1002/HON.2900120205
Saul A. Rosenberg, Autologous Bone Marrow Transplantation in Non-Hodgkin's Lymphoma New England Journal of Medicine. ,vol. 316, pp. 1541- 1542 ,(1987) , 10.1056/NEJM198706113162409